2 October 2023 - Biotechnology company NeuroSense Therapeutics Ltd (Nasdaq: NRSN) declared on Monday that it has decided to end its 'at-the-market' (ATM) equity offering program, effective 4 October 2023.The company, focused on treatments f...
2 October 2023 - Clinical-stage biopharmaceutical company SAB Biotherapeutics (Nasdaq:SABS) announced on Monday a private placement agreement with accredited investors, raising up to USD130m in gross proceeds.This funding will propel the development ...
2 October 2023 - Clinical stage biopharmaceutical company Acurx Pharmaceuticals Inc (NASDAQ:ACXP) announced on Monday the early discontinuation of the Phase 2b clinical trial for its lead antibiotic candidate, ibezapolstat, targeting Clostridioides d...
2 October 2023 - Biotechnology company Rocket Pharmaceuticals Inc (NASDAQ:RCKT) said on Monday that the US Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) and granted Priority Review for RP-L201 (marnetegragene...
2 October 2023 - Healthcare data and technology solutions provider Veradigm Inc (NASDAQ: MDRX) and Holmusk, a global leader in behavioral health real-world evidence, on Monday announced a new phase in a strategic collaboration. This development invol...